ir policy - genmab a/s
the investor relations website contains information about genmab a/s's business for stockholders, potential investors, and financial analysts.
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-03 | 21.022 |
| 2025-04 | 24.339 |
| 2025-05 | 18.482 |
| Source | Traffic Share |
|---|---|
| search | 47.39% |
| direct | 32.49% |
| referrals | 14.54% |
| social | 4.77% |
| paid referrals | 0.69% |
| 0.11% |
| Region | Percentage |
|---|---|
| United States | 34.52% |
| DK | 31.54% |
| FR | 12.64% |
| Germany | 7.62% |
| United Kingdom | 3.78% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| rinatabart sesutecan | 60 | 600 | $0.00 |
| genmab and j&j deal | 0 | 0 | $0.00 |
| genmab årsrapport 2024 | 2 | 20 | $0.00 |
| genmab årsrapport 2023 | 2 | 20 | $0.00 |
| genmab genmab-acquire-profoundbio-and-its-pipeline-next-generation | 0 | 0 | $0.00 |